MedTrace Logo

Impact of Salovum® and SPC® Flakes on Brain Tumor Induced Edema

NCT06710249 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2025-01-27

No results posted yet for this study

Summary

The objective of this clinical trial is to explore the effects of Salovum®, an egg yolk powder enriched with the endogenous protein antisecretory factor, and SPC® flakes , hydrothermically processed oats, on cerebral edema with clinical symptoms in participants with brain tumors.

The primary questions the trial seeks to answer are:

* Can Salovum® and SPC® flakes have effect on clinical symptoms of tumor-induced cerebral edema?
* Can Salovum® and SPC® flakes induce regression of radiological edema in tumor-induced cerebral edema Additionally, the study will investigate the impact of Salovum® and SPC® flakes in steroid refractory, steroid naïve cerebral edema and type of barin tumor

Researchers will:

Evaluate edema change from baseline by MRI after 14 days Evaluate neurological and cognitive symptoms Register dose of steroid medications

Participants will:

* Ingest Salovum® 11g three times daily for 14 days, thereafter tapered during 14 days
* Ingest SPC® flakes 1g/kg daily from day 7

Conditions

Interventions

DIETARY_SUPPLEMENT

Salovum/SPC flakes

Egg yolk powder and specially processed cereals

Sponsors & Collaborators

  • Lund University

    collaborator OTHER

  • Peter Siesjö

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-27
Primary Completion
2026-01-31
Completion
2026-03-01

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06710249 on ClinicalTrials.gov